ENTITY
Celltrion Pharm

Celltrion Pharm (068760 KS)

116
Analysis
Health CareSouth Korea
Celltrion Pharm Inc. manufactures and sells pharmaceutical products. The Company products inclue drugs for for hepatic diseases, digestion, diabetes, cold and fever, anti-inflammatory, and veterinary medical products. Celltrion also provides pharmaceutical raw materials.
more
01 Feb 2020 13:41

Korea Stock Market Monthly Recap #44 (January 2020)

The top 10 events impacting the Korean stock market, economy, & politics in January were as follows: 1) NEW CORONAVIRUS (WUHAN VIRUS) 2)...

Logo
357 Views
Share
21 Jan 2020 17:51

Korea - Celltrion Shorts Increase, Semco Covering Continues

The Korea Exchange (KRX) publishes outstanding short position data daily with a two day lag. The data below is of the close of 17 January 2020....

Logo
402 Views
Share
bullishCelltrion Inc
16 Jan 2020 14:25

Celltrion Merger: Is It for Real This Time? Why Next Year?

Almost every year, we hear this same old story about the Celltrion merger when we approach the OGM season in March. It has always been Chairman Seo...

Logo
470 Views
Share
16 Jan 2020 11:24

A Potential Merger of Celltrion, Celltrion Healthcare, & Celltrion Pharma?

The Celltrion Group Chairman Seo Jung-Jin made an important announcement at a JP Morgan Conference in San Francisco on January 15th. Chairman Seo...

Logo
553 Views
Share
bearishHKEX
04 Nov 2019 08:45

Stock Short Ideas Within an Index Long Environment

Positioning is quickly shifting to more index net longs and we are on the hunt for stock shorts in Asia given the more bullish Q4 seasonality and...

Share
x